1. Home
  2. RCON vs TVGN Comparison

RCON vs TVGN Comparison

Compare RCON & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

N/A

Current Price

$0.90

Market Cap

25.4M

Sector

Energy

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.35

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
RCON
TVGN
Founded
2007
2020
Country
China
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Blank Checks
Sector
Energy
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
21.3M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
RCON
TVGN
Price
$0.90
$6.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 113.0K
4.9K
Earning Date
09-30-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $6,430,788.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.08
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.02
$0.14
52 Week High
$6.42
$32.90

Technical Indicators

Market Signals
Indicator
RCON
TVGN
Relative Strength Index (RSI) 38.53 44.94
Support Level $0.79 $6.15
Resistance Level $1.04 $7.65
Average True Range (ATR) 0.11 0.49
MACD -0.01 -0.03
Stochastic Oscillator 13.29 41.53

Price Performance

Historical Comparison
RCON
TVGN

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: